Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2010-03-18 16:07:28 UTC |
---|
Update Date | 2023-07-07 20:53:59 UTC |
---|
HMDB ID | HMDB0013431 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | PC(O-38:2) |
---|
Description | PC(O-18:1(9Z)/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-18:1(9Z)/20:1(11Z)), in particular, consists of one chain of Oleyl alcohol at the C-1 position and one chain of eicosenoic acid at the C-2 position. The Oleyl alcohol moiety is derived from beef fat, fish oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. |
---|
Structure | CCCCCCCC\C=C/CCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C InChI=1S/C46H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h20-23,45H,6-19,24-44H2,1-5H3/b22-20-,23-21-/t45-/m1/s1 |
---|
Synonyms | Value | Source |
---|
1-Oleyl-2-eicosenoyl-sn-glycero-3-phosphocholine | HMDB | Gpcho(18:1/20:1) | HMDB | Gpcho(18:1n9/20:1n9) | HMDB | Gpcho(18:1W9/20:1W9) | HMDB | Gpcho(38:2) | HMDB | Lecithin | HMDB | PC Ae C38:2 | HMDB | PC(18:1/20:1) | HMDB | PC(18:1n9/20:1n9) | HMDB | PC(18:1W9/20:1W9) | HMDB | PC(38:2) | HMDB | PC(O-38:2) | HMDB | Phosphatidylcholine(18:1/20:1) | HMDB | Phosphatidylcholine(18:1n9/20:1n9) | HMDB | Phosphatidylcholine(18:1W9/20:1W9) | HMDB | Phosphatidylcholine(38:2) | HMDB | 1-(9Z-Octadecenyl)-2-(11-eicosenoyl)-sn-glycero-3-phosphocholine | HMDB | PC(o-18:1(9Z)/20:1(11Z)) | Lipid Annotator |
|
---|
Chemical Formula | C46H90NO7P |
---|
Average Molecular Weight | 800.1831 |
---|
Monoisotopic Molecular Weight | 799.645490751 |
---|
IUPAC Name | (2-{[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-[(9Z)-octadec-9-en-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium |
---|
Traditional Name | (2-{[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-[(9Z)-octadec-9-en-1-yloxy]propyl phosphonato]oxy}ethyl)trimethylazanium |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCCCCCC\C=C/CCCCCCCCCC(=O)O[C@]([H])(COCCCCCCCC\C=C/CCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C |
---|
InChI Identifier | InChI=1S/C46H90NO7P/c1-6-8-10-12-14-16-18-20-22-24-25-27-29-31-33-35-37-39-46(48)54-45(44-53-55(49,50)52-42-40-47(3,4)5)43-51-41-38-36-34-32-30-28-26-23-21-19-17-15-13-11-9-7-2/h20-23,45H,6-19,24-44H2,1-5H3/b22-20-,23-21-/t45-/m1/s1 |
---|
InChI Key | OALUPVKKQYLXOY-OGPXCXTMSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1-alkyl,2-acylglycero-3-phosphocholines. These are glycerophosphocholines that carry exactly one acyl chain attached to the glycerol moiety through an ester linkage at the O2-position, and one alkyl chain attached through an ether linkage at the O1-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphocholines |
---|
Direct Parent | 1-alkyl,2-acylglycero-3-phosphocholines |
---|
Alternative Parents | |
---|
Substituents | - 1-alkyl,2-acylglycero-3-phosphocholine
- Phosphocholine
- Fatty acid ester
- Dialkyl phosphate
- Glycerol ether
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Fatty acyl
- Alkyl phosphate
- Tetraalkylammonium salt
- Quaternary ammonium salt
- Carboxylic acid ester
- Carboxylic acid derivative
- Dialkyl ether
- Ether
- Monocarboxylic acid or derivatives
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Amine
- Organic nitrogen compound
- Organooxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organic salt
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | Biological locationRoute of exposureSourceEndogenousExogenousFood- Food (HMDB: HMDB0013431)
Animal originMilk and milk productUnfermented milk- Cow milk, pasteurized, vitamin A + D added, 0% fat (FooDB: FOOD00889)
- Cow milk, pasteurized, vitamin A + D added, 1% fat (FooDB: FOOD00890)
- Cow milk, pasteurized, vitamin A + D added, 2% fat (FooDB: FOOD00891)
- Cow milk, pasteurized, vitamin D added, 3.25% fat (FooDB: FOOD00892)
- Exogenous (HMDB: HMDB0013431)
|
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 10V, Positive-QTOF | splash10-000l-9142212130-41bf266ffd8e7a7ac1c4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 20V, Positive-QTOF | splash10-0fto-6293113100-1b91e7fb0d86a78a438c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 40V, Positive-QTOF | splash10-002r-9065004200-e8080fe264c747e18a22 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 10V, Negative-QTOF | splash10-052b-0034000900-eed7ecf366e6a11f2b54 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 20V, Negative-QTOF | splash10-05mk-2093303700-9aa782290be67ae06c7e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 40V, Negative-QTOF | splash10-05ox-6194200000-7a6d0230ed7c8faa5af5 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 10V, Negative-QTOF | splash10-001i-0000000090-e3eafc4e48ef2cc837f7 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 20V, Negative-QTOF | splash10-001i-0000000090-e3eafc4e48ef2cc837f7 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 40V, Negative-QTOF | splash10-05fr-0006300910-0743e6f982195fe56b59 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 10V, Positive-QTOF | splash10-0udi-0000000090-2c84f280058e6251782c | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 20V, Positive-QTOF | splash10-0udi-0000000090-2c84f280058e6251782c | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 40V, Positive-QTOF | splash10-0f89-1900141160-8e8a273e46acac7d1fe9 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 10V, Negative-QTOF | splash10-0002-0000000900-5b7c6c4e3527ac34af63 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 20V, Negative-QTOF | splash10-0002-0021001900-cf5926f10d00a642105c | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - PC(O-38:2) 40V, Negative-QTOF | splash10-066r-5038900000-391b73e38847319f8eb7 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 1.96 +/- 0.51 uM | Children (1-13 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.84 (1.48-2.3) uM | Infant (0-1 year old) | Not Available | Normal | | details | Blood | Detected and Quantified | 0.90-6.00 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 1.98 (0.05-3.60) uM | Adolescent (13-18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 2.00 +/- 0.60 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 2.19(0.54) uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.8 (0.58-1.28) uM | Newborn (0-30 days old) | Not Available | Normal | | details | Feces | Detected and Quantified | 0.04 +/- 0.06 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | Feces | Detected and Quantified | 0.06 +/- 0.06 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.0017 +/- 0.0031 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 0.0015 (0.0007-0.0023) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 1.25 (0.80-4.20) uM | Adolescent (13-18 years old) | Both | Acetaminophen overdose | | details | Blood | Detected and Quantified | 1.55 +/- 0.48 uM | Children (1-13 years old) | Both | Obese | | details | Blood | Detected and Quantified | 1.9462 (1.9687) uM | Adult (>18 years old) | Female | Pregnancy with fetus having congenital heart defect | | details | Blood | Detected and Quantified | 3.0116 (0.9756) uM | Adult (>18 years old) | Female | Pregnancy | | details | Blood | Detected and Quantified | 1.43 +/- 0.40 uM | Children (1-13 years old) | Both | Obesity | | details | Blood | Detected and Quantified | 1.67 +/- 0.52 uM | Children (1-13 years old) | Both | Obesity | | details | Blood | Detected and Quantified | 1.89(0.64) uM | Adult (>18 years old) | Both | Heart failure with preserved ejection fraction | | details | Blood | Detected and Quantified | 3.6 +/- 2.1 uM | Children (1-13 years old) | Both | Obese | | details | Blood | Detected and Quantified | 3.7 +/- 2.5 uM | Children (1-13 years old) | Both | Obese | | details | Blood | Detected and Quantified | 3.5 +/- 2.0 uM | Children (1-13 years old) | Both | Obese | | details | Blood | Detected and Quantified | 3.8 +/- 2.6 uM | Children (1-13 years old) | Both | Obese | | details | Blood | Detected and Quantified | 1.95 (1.09-5.48) uM | Adolescent (13-18 years old) | Both | Pain or fever | | details | Urine | Detected and Quantified | 0.0009 +/- 0.0008 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 0.0008 +/- 0.0009 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Pregnancy |
---|
- Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1. [PubMed:24704061 ]
| Obesity |
---|
- Reinehr T, Wolters B, Knop C, Lass N, Hellmuth C, Harder U, Peissner W, Wahl S, Grallert H, Adamski J, Illig T, Prehn C, Yu Z, Wang-Sattler R, Koletzko B: Changes in the serum metabolite profile in obese children with weight loss. Eur J Nutr. 2015 Mar;54(2):173-81. doi: 10.1007/s00394-014-0698-8. Epub 2014 Apr 17. [PubMed:24740590 ]
- Wahl S, Yu Z, Kleber M, Singmann P, Holzapfel C, He Y, Mittelstrass K, Polonikov A, Prehn C, Romisch-Margl W, Adamski J, Suhre K, Grallert H, Illig T, Wang-Sattler R, Reinehr T: Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts. 2012;5(5):660-70. doi: 10.1159/000343204. Epub 2012 Oct 4. [PubMed:23108202 ]
- Simone Wahl, Christina Holzapfel, Zhonghao Yu, Michaela Breier, Ivan Kondofersky, Christiane Fuchs, Paula Singmann, Cornelia Prehn, Jerzy Adamski, Harald Grallert, Thomas Illig, Rui Wang-Sattler, Thomas Reinehr (2013). Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children. Metabolomics.
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB029431 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 53481729 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 89863 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | MDB00030048 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Divecha N, Irvine RF: Phospholipid signaling. Cell. 1995 Jan 27;80(2):269-78. [PubMed:7834746 ]
- Cevc, Gregor (1993). Phospholipids Handbook. Marcel Dekker.
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|